These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

234 related items for PubMed ID: 17436565

  • 21. NLCQ-1 (NSC 709257) in combination with radiation against human glioma U251 xenografts.
    Papadopoulou MV, Bloomer WD, Hollingshead MG.
    Anticancer Res; 2005; 25(3B):1865-9. PubMed ID: 16158918
    [Abstract] [Full Text] [Related]

  • 22. 9-[3-(2-Nitro-1-imidazolyl)propylamino]-cyclopenteno[b]quinoline hydrochloride (NLCPQ-1). A novel DNA-affinic bioreductive agent as chemosensitizer: mechanistic studies. II.
    Papadopoulou MV, Rosenzweig HS, Ji M, Khan SH, Bloomer WD.
    Oncol Res; 1998; 10(3):163-73. PubMed ID: 9700727
    [Abstract] [Full Text] [Related]

  • 23. Hypoxia-selective antitumor agents. 14. Synthesis and hypoxic cell cytotoxicity of regioisomers of the hypoxia-selective cytotoxin 5-[N,N-bis(2-chloroethyl)amino]-2,4-dinitrobenzamide.
    Palmer BD, Wilson WR, Anderson RF, Boyd M, Denny WA.
    J Med Chem; 1996 Jun 21; 39(13):2518-28. PubMed ID: 8691449
    [Abstract] [Full Text] [Related]

  • 24. Neocarzinostatin-mediated DNA damage and repair in wild-type and repair-deficient Chinese hamster ovary cells.
    Kuo WL, Meyn RE, Haidle CW.
    Cancer Res; 1984 May 21; 44(5):1748-51. PubMed ID: 6231985
    [Abstract] [Full Text] [Related]

  • 25. The Arg280His polymorphism in X-ray repair cross-complementing gene 1 impairs DNA repair ability.
    Takanami T, Nakamura J, Kubota Y, Horiuchi S.
    Mutat Res; 2005 Apr 04; 582(1-2):135-45. PubMed ID: 15781218
    [Abstract] [Full Text] [Related]

  • 26. Enhanced radiation-induced cell killing by carboplatin in cells of repair-proficient and repair-deficient cell lines.
    Yang L, Douple EB, O'Hara JA, Crabtree RA, Eastman A.
    Radiat Res; 1995 Nov 04; 144(2):230-6. PubMed ID: 7480650
    [Abstract] [Full Text] [Related]

  • 27. A mitotic spindle requirement for DNA damage-induced apoptosis in Chinese hamster ovary cells.
    Johnson PA, Clements P, Hudson K, Caldecott KW.
    Cancer Res; 1999 Jun 01; 59(11):2696-700. PubMed ID: 10363994
    [Abstract] [Full Text] [Related]

  • 28. The importance of the ERCC1/ERCC4[XPF] complex for hypoxic-cell radioresistance does not appear to derive from its participation in the nucleotide excision repair pathway.
    Murray D, Rosenberg E.
    Mutat Res; 1996 Dec 02; 364(3):217-26. PubMed ID: 8960133
    [Abstract] [Full Text] [Related]

  • 29. Mitochondrial dysfunction after aerobic exposure to the hypoxic cytotoxin tirapazamine.
    Wouters BG, Delahoussaye YM, Evans JW, Birrell GW, Dorie MJ, Wang J, MacDermed D, Chiu RK, Brown JM.
    Cancer Res; 2001 Jan 01; 61(1):145-52. PubMed ID: 11196153
    [Abstract] [Full Text] [Related]

  • 30. THNLA-1: a DNA-targeted bioreductive agent as chemosensitizer in vitro and in vivo.
    Papadopoulou MV, Ji M, Bloomer WD.
    In Vivo; 1996 Jan 01; 10(1):49-57. PubMed ID: 8726811
    [Abstract] [Full Text] [Related]

  • 31. XRCC1 and DNA polymerase beta interaction contributes to cellular alkylating-agent resistance and single-strand break repair.
    Wong HK, Wilson DM.
    J Cell Biochem; 2005 Jul 01; 95(4):794-804. PubMed ID: 15838887
    [Abstract] [Full Text] [Related]

  • 32. Nucleotide excision repair genes as determinants of cellular sensitivity to cyclophosphamide analogs.
    Andersson BS, Sadeghi T, Siciliano MJ, Legerski R, Murray D.
    Cancer Chemother Pharmacol; 1996 Jul 01; 38(5):406-16. PubMed ID: 8765433
    [Abstract] [Full Text] [Related]

  • 33. DNA repair deficiency and acetaldehyde-induced chromosomal alterations in CHO cells.
    Mechilli M, Schinoppi A, Kobos K, Natarajan AT, Palitti F.
    Mutagenesis; 2008 Jan 01; 23(1):51-6. PubMed ID: 17989147
    [Abstract] [Full Text] [Related]

  • 34. Cytotoxic synergy between pyrazoloacridine (NSC 366140) and cisplatin in vitro: inhibition of platinum-DNA adduct removal.
    Adjei AA, Budihardjo II, Rowinsky EK, Kottke TJ, Svingen PA, Buckwalter CA, Grochow LB, Donehower RC, Kaufmann SH.
    Clin Cancer Res; 1997 May 01; 3(5):761-70. PubMed ID: 9815747
    [Abstract] [Full Text] [Related]

  • 35. Effect of ERCC-1 overexpression on sensitivity of Chinese hamster ovary cells to DNA damaging agents.
    Bramson J, Panasci LC.
    Cancer Res; 1993 Jul 15; 53(14):3237-40. PubMed ID: 8324733
    [Abstract] [Full Text] [Related]

  • 36. Advantage of combining NLCQ-1 (NSC 709257) with radiation in treatment of human head and neck xenografts.
    Papadopoulou MV, Bloomer WD, Taylor AP, Hernandez M, Blumenthal RD, Hollingshead MG.
    Radiat Res; 2007 Jul 15; 168(1):65-71. PubMed ID: 17722994
    [Abstract] [Full Text] [Related]

  • 37. Production of DNA double-strand breaks by interactions between carboplatin and radiation: a potential mechanism for radiopotentiation.
    Yang LX, Douple EB, O'Hara JA, Wang HJ.
    Radiat Res; 1995 Sep 15; 143(3):309-15. PubMed ID: 7652169
    [Abstract] [Full Text] [Related]

  • 38. N-[2-(2-methyl-5-nitroimidazolyl)ethyl]-4-(2-nitroimidazolyl)butanamide (NSC 639862), a bisnitroimidazole with enhanced selectivity as a bioreductive drug.
    Moselen JW, Hay MP, Denny WA, Wilson WR.
    Cancer Res; 1995 Feb 01; 55(3):574-80. PubMed ID: 7834627
    [Abstract] [Full Text] [Related]

  • 39. Homologous recombination repair-dependent cytotoxicity of the benzotriazine di-N-oxide CEN-209: comparison with other hypoxia-activated prodrugs.
    Hunter FW, Wang J, Patel R, Hsu HL, Hickey AJ, Hay MP, Wilson WR.
    Biochem Pharmacol; 2012 Mar 01; 83(5):574-85. PubMed ID: 22182429
    [Abstract] [Full Text] [Related]

  • 40. In vivo and in vitro evaluation of the alkylating agent carmethizole.
    Elliott WL, Fry DW, Anderson WK, Nelson JM, Hook KE, Hawkins PA, Leopold WR.
    Cancer Res; 1991 Sep 01; 51(17):4581-7. PubMed ID: 1873802
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.